Application 213301
- Type
- ANDA
- Sponsor
- UNICHEM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 50MG | No | No |
| 002 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 100MG | No | No |
| 003 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 200MG | No | No |
| 004 | CELECOXIB | CELECOXIB | CAPSULE;ORAL | 400MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213301-001 | CELECOXIB | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | ||
| A213301-002 | CELECOXIB | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | ||
| A213301-003 | CELECOXIB | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | ||
| A213301-004 | CELECOXIB | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | d4dbc9d85df4… | ||
| 2026-11-14 07:37:17 | 2026-10 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213301-001 | CELECOXIB | 50MG | CAPSULE / ORAL | 2021-01-12 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213301-002 | CELECOXIB | 100MG | CAPSULE / ORAL | 2021-01-12 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213301-003 | CELECOXIB | 200MG | CAPSULE / ORAL | 2021-01-12 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A213301-004 | CELECOXIB | 400MG | CAPSULE / ORAL | 2021-01-12 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-03-09 01:35 UTC | 2022-03 | A213301-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A213301-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A213301-003 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A213301-004 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-003 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A213301-004 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A213301-004 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-002 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-003 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A213301-004 | AB | 1 | 5aa47cf7b7d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CELECOXIB | CELECOXIB | Bryant Ranch Prepack | 47be1d99-eebb-42f9-80d9-291a024b1364 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| Celecoxib | CELECOXIB | Avet Pharmaceuticals Inc. | 4bc96d0c-b484-3cee-e063-6294a90a9193 | 2026-03-15 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | ScieGen Pharmaceuticals, Inc. | 8709cbe7-3de1-4908-a0a9-53002bcee15b | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | Direct Rx | ac87b4f9-3f66-8cf7-e053-2995a90ade0f | 2026-03-06 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| Celecoxib | CELECOXIB | Sportpharm LLC | 528a6f12-9878-4005-8fc2-5997adbb287f | 2026-02-28 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| celecoxib | CELECOXIB | Sportpharm LLC | 1ae11faa-5bbe-49b7-a4dd-b573c304cf66 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | Qingdao BAHEAL Pharmaceutical Co., Ltd. | 87c16a33-5eb0-40b0-a020-ed924326f697 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| CELECOXIB | CELECOXIB | Northwind Health Company, LLC | f874eddf-b2f3-6830-e053-6394a90ade7a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| CELECOXIB | CELECOXIB | Northwind Health Company, LLC | f2a0db9f-174b-1603-e053-2995a90a79a3 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| celecoxib | CELECOXIB | Northwind Health Company, LLC | c213e224-c2fb-726e-e053-2a95a90a21c5 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | Northwind Health Company, LLC | dabfb290-0a7f-3429-e053-2a95a90ae04c | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| CELECOXIB | CELECOXIB | Northwind Health Company, LLC | dac05189-4acf-d6bb-e053-2a95a90a46a9 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| Celecoxib | CELECOXIB | RedPharm Drug | 2fbaa580-f33a-417d-e063-6294a90ad7df | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Yiling Pharmaceutical, Inc. | 43979279-867b-4303-8f30-fc58ae75a069 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Chartwell RX, LLC | a99a67f3-ccaa-4d54-8922-d6dd30fba274 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Alembic Pharmaceuticals Limited | 14e8d788-e44c-4a40-8678-25cf45fed477 | 2025-09-18 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| CELECOXIB | CELECOXIB | PHOENIX RX LLC | 3a669c28-fbc7-827c-e063-6394a90a0829 | 2025-08-03 | Boxed warning, Warnings, Adverse reactions | CELECOXIB CELECOXIB |
| VYSCOXA | CELECOXIB | Carwin Pharmaceutical Associates, LLC | 5094d47e-f791-4190-9397-b7500143a74d | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | CELECOXIB |
| Celecoxib | CELECOXIB | PHOENIX RX LLC | 3a7b127e-c919-418f-e063-6394a90a06d0 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
| Celecoxib | CELECOXIB | Proficient Rx LP | 3a450db8-313c-4120-9b8e-58c956323fa4 | 2025-06-01 | Boxed warning, Warnings, Adverse reactions | Celecoxib CELECOXIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 29300-157 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-157 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-157 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-158 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-158 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-158 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-373 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-373 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-373 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-374 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-374 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |
| 29300-374 | Celecoxib | Celecoxib | Unichem Pharmaceuticals (USA), Inc. | ANDA | Current |